Open Access Highly Accessed Research article

The endogenous and reactive depression subtypes revisited: integrative animal and human studies implicate multiple distinct molecular mechanisms underlying major depressive disorder

Karim Malki*, Robert Keers*, Maria Grazia Tosto, Anbarasu Lourdusamy, Lucia Carboni, Enrico Domenici, Rudolf Uher, Peter McGuffin and Leonard C Schalkwyk

BMC Medicine 2014, 12:73  doi:10.1186/1741-7015-12-73

PubMed Commons is an experimental system of commenting on PubMed abstracts, introduced in October 2013. Comments are displayed on the abstract page, but during the initial closed pilot, only registered users can read or post comments. Any researcher who is listed as an author of an article indexed by PubMed is entitled to participate in the pilot. If you would like to participate and need an invitation, please email, giving the PubMed ID of an article on which you are an author. For more information, see the PubMed Commons FAQ.

Authors provide further acknowledgements

Ursula D'Souza   (2014-07-02 16:56)  BMC

The editors of BMC Medicine have posted the comment below on behalf of the authors who wish to include more information in the acknowledgements section.

KM is supported by an MRC grant (G9817803). The Genome-Based Therapeutic Drugs for Depression study was funded by a European Commission Framework 6 grant, EC Contract Ref: LSHB-CT-2003–503428. The Biomedical Research Centre for Mental Health at the Institute of Psychiatry, King’s College London and South London, and Maudsley National Health Service Foundation Trust (funded by the National Institute for Health Research, Department of Health, United Kingdom) and GlaxoSmithKline contributed by funding add-on projects at the London Centre. Dr. Uher is supported by the Canada Research Chairs program ( RK is supported by an MRC Population Health Scientist Award (MR/K021281/1).

Competing interests

None declared


Post a comment